Shih Alvin Insider Trades

Insider Trading History

Track insider trading activity for Shih Alvin. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Zevra Therapeutics
Zevra Therapeutics ZVRA
Director
Holding Value $392k 30,000 shares
Last Trade
Jun 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$335k 30,000 shares
$11.17
$13.06
Zevra Therapeutics
Zevra Therapeutics ZVRA
Director
Holding Value $261k 20,000 shares
Last Trade
Sep 12, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$158k 20,000 shares
$7.89
$13.06
Zevra Therapeutics
Zevra Therapeutics ZVRA
Director
Holding Value $392k 30,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$259k 30,000 shares
$8.62
$13.06
Zevra Therapeutics
Zevra Therapeutics ZVRA
Director
Holding Value $512k 39,200 shares
Last Trade
May 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$192k 39,200 shares
$4.89
$13.06
Zevra Therapeutics
Zevra Therapeutics ZVRA
Director
Holding Value $768k 58,800 shares
Last Trade
Jan 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$336k 58,800 shares
$5.72
$13.06
Travere Therapeutics
Travere Therapeutics TVTX
EVP Of Research & Development
Holding Value $8.98M 158,334 shares
Last Trade
Sep 01, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$142k 8,750 shares
$16.24
$56.74
Travere Therapeutics
Travere Therapeutics TVTX
EVP Of Research & Development
Holding Value $9.48M 167,084 shares
Last Trade
Jun 01, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$155k 8,750 shares
$17.75
$56.74
Travere Therapeutics
Travere Therapeutics TVTX
EVP Of Research & Development
Holding Value $3.4M 60,000 shares
Last Trade
May 19, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$974k 60,000 shares
$16.23
$56.74
Travere Therapeutics
Travere Therapeutics TVTX
EVP Of Research & Development
Holding Value $9.98M 175,834 shares
Last Trade
Mar 01, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$126k 8,750 shares
$14.35
$56.74
Travere Therapeutics
Travere Therapeutics TVTX
EVP Of Research & Development
Holding Value $10.5M 184,584 shares
Last Trade
Dec 09, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$182k 8,750 shares
$20.83
$56.74
Travere Therapeutics
Travere Therapeutics TVTX
EVP Of Research & Development
Holding Value $11.2M 197,286 shares
Last Trade
Oct 06, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$176k 8,750 shares
$20.12
$56.74
Travere Therapeutics
Travere Therapeutics TVTX
EVP Of Research & Development
Holding Value $3.4M 60,000 shares
Last Trade
Jul 01, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.95M 60,000 shares
$32.49
$56.74
Travere Therapeutics
Travere Therapeutics TVTX
EVP Of Research & Development
Holding Value $11.5M 202,084 shares
Last Trade
Jun 26, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$913k 27,916 shares
$32.70
$56.74

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up